Crossmark

Risk of false-positive findings in the assessment of small nerve fibers in healthy subjects

Published Online: 2026-01-14

Published Print: 2026-01

Authors

Breville, Gautier https://orcid.org/0000-0003-0890-1981
Sukockiene, Egle

Accorroni, Alice

Lalive, Patrice H.

Lascano, Agustina M.
License Information

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2026-01-14
More Information

Article History

Received: 12 May 2025

Revised: 7 July 2025

Accepted: 10 July 2025

First Online: 14 January 2026

Declarations

:

: GB, SE and AA has nothing to disclose. AL received travelling fees from UCB and Takeda; honoraria for advisory fees from Roche and Johnson&Johnson; consulting fees from ADC Therapeutics and Alexion; Webinar from CSL Behring, none related to this study. PL received research grants from Biogen-Idec, Merck Serono, Novartis; honoraria for consulting fees from Biogen-Idec, Geneuro, Genzyme, Merck Serono, Novartis, Sanofi-Aventis, TEVA; honoraria for speaking for Biogen-Idec, CSL Behring, Merck Serono, Novartis, Sanofi-Aventis, TEVA, Roche, non-related to this study.

: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Document is current